Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cell membrane phospholipids form the fundamental structure of all bacterial cytoplasmic membranes, comprising a bilayer of amphipathic molecules with hydrophilic head groups facing outward and hydrophobic tails inward[1][3][5]. These provide membrane integrity, selective permeability, and act as dynamic sites for protein binding, cellular signaling, and environmental interaction[1][5][9]. In Gram-negative bacteria, the outer membrane contains lipopolysaccharide (LPS), a large glycolipid composed of lipid A (a hydrophobic anchor in the membrane), core oligosaccharide, and O-antigen[4][6][10]. The lipid A moiety is primarily responsible for the strong immunostimulatory properties of LPS, which can trigger severe inflammatory responses in animals and humans[4][6]. LPS also confers resistance to some antibiotics and protects bacteria against hostile environments[7][10]. Drugs such as polymyxins exploit the negative charge and hydrophobicity of these bacterial membrane lipids, disrupting membrane integrity to induce cell death; however, these drugs can be toxic to host tissues and bacterial resistance is increasingly reported. The high structural variability of LPS enables immune evasion and forms the basis for bacterial strain serotyping[2][8][10].
Disruption of membrane integrity (pore formation, destabilization: polymyxins, antimicrobial peptides); Binding and neutralization of LPS (LPS antagonists, e.g. eritoran); Inhibition or enhancement of immune recognition (by modulating LPS structure)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell membrane phospholipid and lipopolysaccharide.